Diabetes News and Research

Latest Diabetes News and Research

DRG International to present Aldosterone ELISA Kit at 2016 AACC

DRG International, a leading international medical diagnostic company, will showcase its DRG Aldosterone ELISA Kit at the 2016 AACC in Philadelphia, Pennsylvania on August 02-04.

30 Jul 2016

Roche announces FDA approval of new VENTANA PD-L1 assay

Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC).

30 Jul 2016

Medical professionals express fears in implementing new EHR system in hospitals

As waves of hospitals move from older methods of record keeping to new digital electronic health record (EHR) systems, many medical professionals express fears that implementing an EHR system in their hospital will have dire results, including more errors and higher patient mortality.

29 Jul 2016

MIT researchers develop portable device to manufacture biopharmaceuticals on demand

For medics on the battlefield and doctors in remote or developing parts of the world, getting rapid access to the drugs needed to treat patients can be challenging.

29 Jul 2016

Blood pressure hormone system important for cardiovascular health can promote obesity

New research by University of Iowa scientists helps explain how a hormone system often targeted to treat cardiovascular disease can also lower metabolism and promote obesity.

29 Jul 2016

Moderately high TSH concentrations in infants linked to neurodevelopmental outcomes at school age

Babies born with moderately high concentrations of thyroid stimulating hormone have a higher risk of poor educational and development outcomes at school age, a world-first University of Sydney study reveals.

28 Jul 2016

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.

28 Jul 2016

Psoriasis treatments may help improve cardiovascular symptoms by reducing skin inflammation

Approximately 7.5 million people in the United States have psoriasis, and the impact of this disease goes far beyond its visible effects on the skin.

28 Jul 2016

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection.

28 Jul 2016

Higher nut intake linked to lower levels of inflammatory biomarkers

In a cross-sectional analysis published online today in the American Journal of Clinical Nutrition, researchers looked at the association between habitual nut consumption and inflammatory biomarkers among 5,013 men and women participating in two ongoing prospective cohort studies: the Nurses' Health Study and Health Professionals Follow-up Study.

28 Jul 2016

Lifestyle modification programs to prevent diabetes improve cardio-metabolic profiles

A new study by researchers at Emory's Rollins School of Public Health and the Centers for Disease Control and Prevention shows that lifestyle modification programs modeled on diabetes prevention programs trials not only achieved weight reduction, but also additional metabolic benefits -specifically, reductions in blood sugar, blood pressure, and cholesterol levels.

28 Jul 2016

TSRI scientists develop new dual-targeting drug candidate for treating diabetes and bone disease

In addition to its more obvious ills, type 2 diabetes is a condition closely associated with bone fractures, increasing the risk of fractures twofold. To make matters worse, certain anti-diabetic drugs further increase this risk, particularly in postmenopausal women, severely limiting their treatment options.

28 Jul 2016

Levels of peptide hormone adropin linked to carbohydrate intake

In research featured in the August edition of Obesity, Saint Louis University investigator Andrew Butler, Ph.D., and his team report that levels of the peptide hormone adropin vary based on carbohydrate consumption and appear to be linked to lipid metabolism.

27 Jul 2016

New gene therapeutic approach could save people suffering from muscle wasting disease

A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.

27 Jul 2016

Groundbreaking research opens door for prevention of cardiac fibrosis

Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment.

27 Jul 2016

Women who start menstruation, menopause later in life have increased odds of living to 90-years-old

The number of women living to age 90 in the United States has increased significantly in the past century.

27 Jul 2016

Shorter and longer reproductive durations can raise risk of type 2 diabetes in postmenopausal women

Using data from the Women's Health Initiative, a new study has found that women with reproductive-period durations of less than 30 years had a 37% increased risk of type 2 diabetes compared with women whose reproductive durations were somewhere in the middle (36 to 40 years).

27 Jul 2016

Researchers identify biomarkers to improve prognosis of CKD

Currently, there is no effective method to predict the prognosis of chronic kidney disease (CKD) patients.

27 Jul 2016

Online behavioural intervention provides long-term, sustainable ways to lose weight

New research, led by the University of Southampton, has found that an online behavioural counselling tool is effective at helping people lose weight.

27 Jul 2016

Early and late menopause linked to increased risk of developing type 2 diabetes

Women who begin menopause before age 46 or after 55 have an increased risk of developing type 2 diabetes, according to a study of more than 124,000 women enrolled in the Women's Health Initiative, a large national trial aimed at preventing disease in postmenopausal women.

27 Jul 2016

Diabetes News and Research

Latest Diabetes News and Research

DRG International to present Aldosterone ELISA Kit at 2016 AACC

Roche announces FDA approval of new VENTANA PD-L1 assay

Medical professionals express fears in implementing new EHR system in hospitals

MIT researchers develop portable device to manufacture biopharmaceuticals on demand

Blood pressure hormone system important for cardiovascular health can promote obesity

Moderately high TSH concentrations in infants linked to neurodevelopmental outcomes at school age

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Psoriasis treatments may help improve cardiovascular symptoms by reducing skin inflammation

Valley fever diagnosis often overlooked by primary care physicians

Higher nut intake linked to lower levels of inflammatory biomarkers

Lifestyle modification programs to prevent diabetes improve cardio-metabolic profiles

TSRI scientists develop new dual-targeting drug candidate for treating diabetes and bone disease

Levels of peptide hormone adropin linked to carbohydrate intake

New gene therapeutic approach could save people suffering from muscle wasting disease

Groundbreaking research opens door for prevention of cardiac fibrosis

Women who start menstruation, menopause later in life have increased odds of living to 90-years-old

Shorter and longer reproductive durations can raise risk of type 2 diabetes in postmenopausal women

Researchers identify biomarkers to improve prognosis of CKD

Online behavioural intervention provides long-term, sustainable ways to lose weight

Early and late menopause linked to increased risk of developing type 2 diabetes

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in